PROVIDENCE – The private equity investor Nautic Partners LLC has acquired Atlanta-based Mikart Inc., a contract development and manufacturing organization, or CDMO, that specializes in the development, manufacturing and packaging of solid dose and non-sterile liquid pharmaceuticals, the companies announced Thursday.
Upon the acquisition, Naurtic appointed Michael Kallelis CEO of Mikart. Kallelis was previously vice president of business development at KMC Systems, a New Hampshire-based medical contract manufacturing and engineering firm.
The owner of Mikart, Miguel Arteche, retired following the acquisition. “Nautic offers a compelling combination of health care, manufacturing and financial experience to help Mikart thrive and expand within the rapidly growing CDMO market,” said Arteche.
Chris Vinciguerra, a principal of Nautic said in a statement, “We look forward to helping Mikart increase customer awareness of its compelling offerings and manufacturing excellence, as well as supporting Mike and the company in various growth initiatives.”
Details of the acquisition were not provided. However, it was noted that Nautic generally makes investments of $25 million or more.
Chris Crosby, a managing director of Nautic stated, “We are excited to partner with Mikart given their strong competitive position, high record of quality and great company culture.”
